5 Biotech Penny Stock Gainers on the Radar for March 30
Investors are almost always on the lookout for the latest penny stock gainers, but in the current situation, they need to look into companies far more carefully than before. The coronavirus pandemic has triggered an ... [Read]
Is RockWell Medical (NASDAQ:RMTI) a Good Buy Right Now?
Biopharmaceutical company Rockwell Medical, Inc. (NASDAQ:RMTI) increased by 1.22% to US$2.48 just minutes into after-hours trading on Wednesday after closing at US$2.45, bringing its market cap to US$169 million. Throughout the day Wednesday, RMTI experienced ... [Read]
4 Biotech Penny Stocks That Are Up Over 100% So Far in 2020
So far in March, stock markets have experienced massive losses as the coronavirus outbreak continues to wreak havoc on the global economy. The Dow Jones and S&P 500 plunged, prompting concerns that a global financial ... [Read]
5 Biotech Penny Stock Gainers to Watch on March 13
Biotech has been one of the fastest-growing sectors over the past half a decade or so, garnering a lot of interest in things like biotech penny stocks. Moreover, the onset of the coronavirus pandemic has ... [Read]
Top 5 Penny Stocks to Watch Under $2 on March 12
It’s been said many times before, but penny stocks, especially those under $2, are not for the faint of heart. That especially rings true today, with markets at their weakest point since the 2008 financial ... [Read]
4 Top Small-Cap Biotech Stocks Approaching FDA Approval
In 1992, Congress passed the Prescription Drug User Fee Act (PDUFA), which allows the US Food and Drug Administration (FDA) to collect fees from drug manufacturers to fund the drug review and approval process. The ... [Read]
APOP Stock Soars 50% on a Major Deal with Canndoc
In a development that has taken the market by surprise today, lightly traded APOP stock soared in today’s trading session after important news emerged about Cellect Biotechnology Ltd (NASDAQ:APOP). Investors Cheer the News Cellect has ... [Read]
SGMO Stock Soars After Gene Therapy Deal with Biogen
The signing of an important deal can often send stocks soaring, and that is what happened with SGMO stock on Friday. Late Thursday, it emerged that Sangamo Therapeutics Inc (NASDAQ:SGMO) had signed a big-ticket gene ... [Read]
ENLV Stock Gains 45% as Company is Set to Raise Capacity for Allocetra
Enlivex Therapeutics Ltd (NASDAQ:ENLV), a clinical-stage immunotherapy firm based out of Israel, announced today that it is going to raise the manufacturing capacity of its product Allocetra. What kind of effect will this have on ... [Read]
TOCA Stock Doubles Ahead of Forte Bioscience Merger
TOCA stock has more than doubled today after it was announced that cancer biotech Tocagen Inc (NASDAQ:TOCA) was planning an all-stock merger with privately-held Forte Biosciences. The reverse all-stock acquisition by Forte comes after Tocagen ... [Read]